Ambarella Inc: Form 10-Q for the period ended Oct 31, 2012
Filed with the SEC on Dec 17, 2012 and accepted by EDGAR at Dec 17, 2012, 14:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-08-01 to 2012-10-31 | $35.7m | us-gaap:Revenues |
| Revenue | 9 months2012-02-01 to 2012-10-31 | $89.5m | us-gaap:Revenues |
| Cost of revenue | 3 months2012-08-01 to 2012-10-31 | $12.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2012-02-01 to 2012-10-31 | $28.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2012-08-01 to 2012-10-31 | $23.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2012-02-01 to 2012-10-31 | $60.7m | us-gaap:GrossProfit |
| Research and development | 3 months2012-08-01 to 2012-10-31 | $10.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2012-02-01 to 2012-10-31 | $31.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-08-01 to 2012-10-31 | $4.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2012-02-01 to 2012-10-31 | $12.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-08-01 to 2012-10-31 | $7.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-02-01 to 2012-10-31 | $16.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-08-01 to 2012-10-31 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2012-02-01 to 2012-10-31 | $1.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-08-01 to 2012-10-31 | $6.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-02-01 to 2012-10-31 | $14.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-08-01 to 2012-10-31 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2012-02-01 to 2012-10-31 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-08-01 to 2012-10-31 | $0.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2012-02-01 to 2012-10-31 | $0.55 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-08-01 to 2012-10-31 | 13,415,091 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2012-02-01 to 2012-10-31 | 10,506,293 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2012-02-01 to 2012-10-31 | $9.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2012-02-01 to 2012-10-31 | $997.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-10-31 | $94.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-10-31 | $125.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-10-31 | $129.6m | us-gaap:Assets |
| Current liabilities | At period end2012-10-31 | $26.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-10-31 | $27.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2012-10-31 | $102.0m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2012-10-31 | 26,093,016 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-12-504664. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.